Omlyclo 75 mg/0.5 ml

Omlyclo 75 mg/0.5 ml is a medicine authorised by Swissmedic under authorisation number 69508. The authorisation holder is IQONE HEALTHCARE SWITZERLAND SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 September 2024 and the authorisation is limited until 25 September 2029. ATC code R03DX05 places the medicine in the group Drugs for obstructive airway diseases.

  • Dispensing category B
  • Authorisation number 69508
  • ATC R03DX05
  • Biotechnological medicines
Authorisation data
Authorisation number69508
NameOmlyclo 75 mg/0.5 ml
Full nameOmlyclo 75 mg/0.5 ml, solution injectable en seringue préremplie
Authorisation holderIQONE HEALTHCARE SWITZERLAND SA
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeR03DX05
First authorisation26 September 2024
Authorisation validity25 September 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Omlyclo 75 mg/0.5 ml, solution injectable en seringue préremplieB26 September 2024
2Omlyclo 150 mg/1 ml, solution injectable en seringue préremplieB26 September 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Fertigspritze(n)R03DX0503.04.5.B
21Fertigspritze(n)R03DX0503.04.5.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Omlyclo 75 mg/0.5 ml authorised in Switzerland?

Yes. Omlyclo 75 mg/0.5 ml is authorised by Swissmedic under authorisation number 69508, data as of 01 September 2026. The authorisation is limited until 25 September 2029.

Which dispensing category does Omlyclo 75 mg/0.5 ml have?

Omlyclo 75 mg/0.5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Omlyclo 75 mg/0.5 ml?

The authorisation holder is IQONE HEALTHCARE SWITZERLAND SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com